Stock DNA
Pharmaceuticals & Biotechnology
INR 135 Cr (Micro Cap)
35.00
34
0.00%
0.11
6.60%
1.84
Total Returns (Price + Dividend) 
Latest dividend: 1.5 per share ex-dividend date: Jun-13-2025
Risk Adjusted Returns v/s 
Returns Beta
News
When is the next results date for Smruthi Organics Ltd?
The next results date for Smruthi Organics Ltd is scheduled for 13 May 2026....
Read More
Smruthi Organics Ltd Upgraded to Hold as Technicals Improve and Financials Strengthen
Smruthi Organics Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable shift in technical indicators and improving financial metrics. The micro-cap pharmaceutical company’s recent performance and valuation adjustments have prompted analysts to revise their outlook, signalling cautious optimism amid mixed long-term growth trends.
Read More
Smruthi Organics Ltd is Rated Sell
Smruthi Organics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read More Announcements 
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
06-May-2026 | Source : BSESmruthi Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 inter alia to consider and approve Audited Financial Statements for the quarter and financial year ended 31st March 2026.
Clarification On Website Disclosures For BSE Query
27-Apr-2026 | Source : BSEClarification letter
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
07-Apr-2026 | Source : BSECompliance Certificate- Reg 74(5)
Corporate Actions 
No Upcoming Board Meetings
Smruthi Organics Ltd has declared 15% dividend, ex-date: 31 Jul 26
No Splits history available
Smruthi Organics Ltd has announced 2:1 bonus issue, ex-date: 16 Mar 21
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Eaga Purushotham Malaiah (41.23%)
Smitha Gupta (1.21%)
28.7%
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 30.51% vs -29.46% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is -23.57% vs -32.04% in Dec 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -10.71% vs -12.16% in Sep 2024
Growth in half year ended Sep 2025 is 740.00% vs -103.44% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -17.10% vs -0.08% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 77.44% vs -35.75% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is -19.08% vs -1.28% in Mar 2025
YoY Growth in year ended Mar 2026 is -3.65% vs -0.84% in Mar 2025